Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers.
Turk CM, Fagan-Solis KD, Williams KE, Gozgit JM, Smith-Schneider S, Marconi SA, Otis CN, Crisi GM, Anderton DL, Kilimann MW, Arcaro KF.
Turk CM, et al. Among authors: smith schneider s.
Cancer Cell Int. 2012 May 10;12(1):17. doi: 10.1186/1475-2867-12-17.
Cancer Cell Int. 2012.
PMID: 22574838
Free PMC article.